Back

Non-steroidal MRAs in heart failure and cardio-kidney-metabolic disease: current clinical trial evidence

10 May 2026 (14:32 - 14:40)
Organised by: Logo
Congress Presentation Part of: Non-steroidal mineralocorticoid receptor antagonists: current role and implementation in the management of patients with heart failure Renal Failure and Cardiovascular Disease Open Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Professor Maja Cikes

University Hospital Centre Zagreb, Zagreb (Croatia)

5 More presentations in this session

Presentation thumbnail
Introduction
Professor S. Anker (Berlin, DE)
Video
Presentation thumbnail
Guideline recommendations for steroidal and non-steroidal MRAs in heart failure and cardio-kidney-metabolic disease
Doctor S. Zieroth (Winnipeg, CA)
Slides Video
Presentation thumbnail
Implementation of non-steroidal MRAs in clinical practice
Doctor H. Van Spall (Hamilton, CA)
Slides Video
Presentation thumbnail
Discussion
Presentation thumbnail
Conclusion
Doctor H. Van Spall (Hamilton, CA)
Slides Video

Access the full session

Session thumbnail
Non-steroidal mineralocorticoid receptor antagonists: current role and implementation in the management of patients with heart failure
Video

The Event

Event poster

Heart Failure 2026

10 May 2026 14:32 CET
You may be interested in
thumbnail
Congress Presentation
Non-steroidal mineralocorticoid receptor antagonists (MRAs): standard therapy for HFpEF?
thumbnail
Congress Presentation
Non-steroidal mineralocorticoid receptor antagonists (nsMRAs) in heart failure with mid-range and preserved ejection fraction: establishing a new standard in heart failure care
thumbnail
Congress Presentation
Mineralocorticoid receptor antagonist drugs in HFpEF

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources